The Patent Finder

Adnagen GmbH

Also on record
Records under this name other than the patents Adnagen GmbH holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 5 patents it holds.

Showing 1 to 5 of 5 · Back to Adnagen GmbH

PatentTitleStatus Expires Confidence
US 7,858,757Monoclonal antibodies with specificity for fetal erythroid cells
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,536,312Monoclonal antibodies with specificity for fetal erythroid cells
Formerly held
Term ended
Term ended Aug 17, 2025 · From the USPTO record
Term endedTerm ended Aug 17, 2025From the USPTO record
US 9,194,871Monoclonal antibodies with specificity for fetal erythroid cells
Term ended
Ended no later than Mar 31, 2025 · From the USPTO record
Term endedEnded no later than Mar 31, 2025From the USPTO record
US 9,453,841Monoclonal antibodies with specificity for fetal erythroid cells
Formerly held
Term ended
Ended no later than Mar 31, 2025 · From the USPTO record
Term endedEnded no later than Mar 31, 2025From the USPTO record
US 7,507,528Method and diagnosis kit for selecting and or qualitative and/or quantitative detection of cells
Term ended
Ended no later than May 17, 2022 · From the USPTO record
Term endedEnded no later than May 17, 2022From the USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited